Genmab — Juni 2018
-
Meanwhile the recently new Tisotumab Vedotin trial in Cervical Cancer starts recruiting already - https://www.clinicaltrials.gov/ct2/history/NCT03438396?A=2&B=3&C=merged
-
not sure why this "Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma" trial is still being updated, let alone why it is extended? https://www.clinicaltrials.gov/ct2/history/NCT01716208?A=11&B=12&C=merged
-
this Dara - Prostate Cancer trial has also extended the expected Completion date, by 1 year; can we take that as a positive?
https://www.clinicaltrials.gov/ct2/history/NCT03177460?A=7&B=8&C=merged -
Er der kommet salgstal
for maj måned ? -
du mener recepttal ikke?? de var på 122mill
-
Mange tak mobbyduck1
-
God morgen.

-
Royal..Tusinde tak for solstråle historie.

-
God morgen

-
Dejlig læsning!
Og God morgen 
-
Godmorgen....vi kan vel sammenfatte det til at når det går godt for Genmab(dara) så hjælper det også for de patienter som lider af denne forbandede sygdom.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind